Strata Skin Sciences (SSKN)
(Delayed Data from NSDQ)
$3.19 USD
+0.16 (5.28%)
Updated Sep 23, 2024 09:57 AM ET
2-Buy of 5 2
B Value A Growth C Momentum A VGM
Income Statements
Fiscal Year end for Strata Skin Sciences, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 33 | 36 | 30 | 23 | 32 |
Cost Of Goods | 15 | 14 | 10 | 9 | 11 |
Gross Profit | 18 | 22 | 20 | 14 | 20 |
Selling & Adminstrative & Depr. & Amort Expenses | 27 | 26 | 24 | 18 | 23 |
Income After Depreciation & Amortization | -9 | -5 | -4 | -4 | -3 |
Non-Operating Income | -1 | 0 | 2 | 0 | 0 |
Interest Expense | 2 | 1 | 0 | 0 | 1 |
Pretax Income | -11 | -5 | -3 | -4 | -4 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -11 | -6 | -3 | -4 | -4 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -11 | -6 | -3 | -4 | -4 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -3 | 1 | 0 | 0 | 2 |
Depreciation & Amortization (Cash Flow) | 6 | 6 | 4 | 4 | 5 |
Income After Depreciation & Amortization | -9 | -5 | -4 | -4 | -3 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 3.49 | 3.47 | 3.41 | 3.36 | 3.45 |
Diluted EPS Before Non-Recurring Items | -2.20 | -1.60 | -1.40 | -1.30 | -1.10 |
Diluted Net EPS (GAAP) | -3.10 | -1.60 | -0.80 | -1.30 | -1.10 |
Fiscal Year end for Strata Skin Sciences, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 8.44 | 6.75 | 8.69 | 8.85 | 8.25 |
Cost Of Goods | 3.50 | 3.67 | 3.89 | 3.90 | 3.93 |
Gross Profit | 4.94 | 3.08 | 4.80 | 4.95 | 4.32 |
SG&A, R&D, and Dept/Amort Expenses | 5.42 | 5.97 | 5.96 | 5.57 | 6.28 |
Income After SG&A, R&D, and Dept/Amort Expenses | -0.48 | -2.89 | -1.16 | -0.62 | -1.96 |
Non-Operating Income | 0.92 | 0.05 | 0.08 | 0.09 | -0.89 |
Interest Expense | 0.53 | 0.52 | 0.53 | 0.53 | 0.30 |
Pretax Income | -0.10 | -3.37 | -3.89 | -1.05 | -3.15 |
Income Taxes | 0.00 | 0.00 | -0.09 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -0.10 | -3.37 | -3.79 | -1.05 | -3.15 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -0.10 | -3.37 | -3.79 | -1.05 | -3.15 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 3.51 | 3.51 | 3.50 | 3.49 | 3.49 |
Diluted EPS Before Non-Recurring Items | -0.03 | -1.00 | -0.40 | -0.30 | -0.90 |
Diluted Net EPS (GAAP) | -0.03 | -1.00 | -1.10 | -0.30 | -0.90 |